تاثیر تمرینات تناوبی با شدت بالا بر مقدار سرمی آسپروسین و پروفایل لیپیدی در زنان دارای اضافه وزن و چاقی

Adams, O.P. (2013). The impact of brief high-intensity exercise on blood glucose levels. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 6, 113-22. https://doi.org/10.2147/dmso.s29222.
Ahmadabadi, F., Nakhaei, H., Mogharnasi, M., & Huang, C.J. (2021). Aerobic interval training improves irisin and chemerin levels of both liver and visceral adipose tissues and circulating asprosin in rats with metabolic syndrome. Physiology International, 3(108), 383-397. https://doi.org/10.1556/2060.2021.00182.
Alan, M., Gurlek, B., Yilmaz, A., Aksit, M., Aslanipour, B., Gulhan, I., & Taner, C.E. (2019). Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome. Gynecological Endocrinology, 35(3), 220-223. https://doi.org/10.1080/09513590.2018.1512967.
Beam, W.C., & Adams, G.M. (2011). Aerobic stepping. Exercise physiology laboratory manual. 6th ed. New York (NY): McGraw-Hill, 127-33. 
Bompa, T.O., & Buzzichelli, C. (2019). Periodization-: theory and methodology of training. Human kinetics. 5th edition. pp. 344-349. 
Ceylan, H. I., & Saygın, Ö. (2021). An investigation of the relationship between new fasting hormone asprosin, obesity and acute–chronic exercise: current systematic review. Archives of Physiology and Biochemistry, 127(4), 373-384. https://doi.org/10.1080/13813455.2020.1767652.
Duerrschmid, C., He, Y., Wang, C., Li, C., Bournat, J.C., Romere, C., & Jain, M. (2017). Asprosin is a centrally acting orexigenic hormone. Nature Medicine, 23(12), 1444-1453. https://doi.org/10.1038/nm.4432.
Festiawan, R., Hoi, L. B., Siswantoyo, N., Kusuma, I. J., Heza, F. N., Wahono, B. S., ... & Sumartiningsih, S. (2021). high-intensity interval training, fartlek training & oregon circuit training: what are the best exercises to increase vo2 max. Annals of Tropical Medicine & Public Health, 24(03), 0-10. https://doi.org/10.36295/asro.2021.24363.
Gerosa-Neto, J., Antunes, B.M., Campos, E.Z., Rodrigues, J., Ferrari, G.D., Neto, J.C.R., & Bueno, C.R. (2016). Impact of long-term high-intensity interval and moderate-intensity continuous training on subclinical inflammation in overweight/obese adults. Journal of Exercise Rehabilitation, 12(6), 575. https://doi.org/10.12965/jer.1632770.385.
Gholaman, M., Gholami, M., Azarbayjani, M.A., & Abed Natanzi, H. (2021). The effect of high intensity interval training and moderate intensity continuous training on the levels of cardiotrophin-1and insulin resistance in women with type 2 diabetes. Journal of Basic Research in Medical Sciences, 8(1), 67-75. https://doi.org/10.20900/agmr20220007.
Gibala, M.J., Little, J.P., MacDonald, M.J., & Hawley, J.A. (2012). Physiological adaptations to low‐volume, high‐intensity interval training in health and disease. The Journal of Physiology, 590(5), 1077-1084. https://doi.org/10.1113/jphysiol.2011.224725.
Guiraud, T., Labrunée, M., Pillard, F., Granger, R., Bousquet, M., Richard, L., ... & Gremeaux, V. (2014). Copyeditor: Patricia Llenado.  American Journal of Physical, 894(9115/14), 0000-0000. https://doi.org/10.1097/PHM.0000000000000181 
Ham, D., & Joung, H. (2020). Understanding the associations between dietary antioxidants and obesity. Journal of Obesity & Metabolic Syndrome, 29(3), 163. https://doi.org/10.7570/jomes20070.
Hatipoglu, H. (2020). Increased serum circulating asprosin levels in children with obesity. Pediatrics International: Official Journal of the Japan Pediatric Society, 62, 467–476. https://doi.org/10.1111/ped.14176.
Hong, T., Li, J. Y., Wang, Y. D., Qi, X. Y., Liao, Z. Z., Bhadel, P., ... & Xiao, X. H. (2021). High serum asprosin levels are associated with presence of metabolic syndrome. International Journal of Endocrinology, 2021, 1-7. https://doi.org/10.1155/2021/6622129.
Hunschede, S., Kubant, R., Akilen, R., Thomas, S., & Anderson, G.H. (2017). Decreased appetite after high-intensity exercise correlates with increased plasma interleukin-6 in normal-weight and overweight/obese boys. Current Developments in Nutrition, 1(3), e000398. https://doi.org/10.3945/cdn.116.000398.
Jahangiri, M., Shahrbanian, S., & Hackney, A.C. (2021). Changes in the level of Asprosin as a novel adipocytokine after different types of resistance training. Journal of Chemical Health Risks, 11(Spec Issue), 179-188. 
Johnson, R., McNutt, P., MacMahon, S., & Robson, R. (1997). Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clinical Chemistry, 43(11), 2183-2184. https://doi.org/10.1093/clinchem/43.11.2183.
Jung, T.W., Kim, H.C., Kim, H.U., Park, T., Park, J., Kim, U., & Jeong, J H. (2019). Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscle. Journal of Cellular Physiology, 234(11), 20888-20899. https://doi.org/10.1002/jcp.28694.
Kantorowicz, M., Szymura, J., Szygula, Z., Kusmierczyk, J., Maciejczyk, M., & Wiecek, M. (2021). Nordic walking at maximal fat oxidation intensity decreases circulating asprosin and visceral obesity in women with metabolic disorders. Frontiers in Physiology, 12, 726783. https://doi.org/10.3389/fphys.2021.726783.
Karstoft, K., Winding, K., Knudsen, S. H., Nielsen, J. S., Thomsen, C., Pedersen, B. K., & Solomon, T. P. (2013). The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes Care, 36(2), 228-236. https://doi.org/10.2337/dc12-0658.
Ko, J.R., Seo, D.Y., Kim, T.N., Park, S.H., Kwak, H.-B., Ko, K.S., . . . & Han, J. (2019). Aerobic exercise training decreases hepatic asprosin in diabetic rats. Journal of Clinical Medicine, 8(5), 666. https://doi.org/10.3390/jcm8050666.
Li, E., Shan, H., Chen, L., Long, A., Zhang, Y., Liu, Y., & Li, T. (2019). OLFR734 mediates glucose metabolism as a receptor of asprosin. Cell Metabolism, 30(2), 319-328. e318. https://doi.org/10.1016/j.cmet.2019.05.022.
Li, X., Liao, M., Shen, R., Zhang, L., Hu, H., Wu, J., ... & Zheng, H. (2018). Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases. Mediators of Inflammation, 2018, 1-12. https://doi.org/10.1155/2018/7375294.
Löllgen, H., Böckenhoff, A., & Knapp, G. (2009). Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories. International Journal of Sports Medicine, 30(03), 213-224. https://doi.org/10.1055/s-0028-1128150.
Mabhout Moghadam, T., Mosaferi Ziaaldini, M., Fathei, M., & Attarzadeh Hoseini, S. R. (2020). Review the effect of high intensity interval training on obesity-related hormones. Researches in Sport Sciences and Medical Plants, 1(1), 1-18. [In Persian]. https://doi.org/10.34172/hmj.2021.26.
Ma, H., Zhang, G., Mou, C., Fu, X., & Chen, Y. (2018). Peripheral CB1 receptor neutral antagonist, AM6545, ameliorates hypometabolic obesity and improves adipokine secretion in monosodium glutamate induced obese mice. Frontiers in Pharmacology, 9, 156. https://doi.org/10.3389/fphar.2018.00156.
Margiana, R., Jusuf, A.A., & Lestari, S.W. (2009). Immunohistochemistry detection method of rejection reaction of human umbilical cord derived mesenchymal stem cell on rat sciatic nerve tissue. Journal of Global Pharma Technology, 10(07), 330-342.
Martins, C., Morgan, L., & Truby, H. (2008). A review of the effects of exercise on appetite regulation: an obesity perspective. International Journal of Obesity, 32(9), 1337-1347. https://doi.org/10.1038/ijo.2008.98.
Mirzaei, M., & Nikahi, F. (2020). Investigating the relationship between physical activity and blood lipid profile in Yazd residents: Resultsof Yazd health study (Yas). Scientific Research Monthly of Yazd Shahid Sadoughi University of Medical Sciences, 28(7), 2819-2832. [In Persian]. https://doi.org/10.18502/ssu.v28i7.4266.
Nakhaei, H., Mogharnasi, M., & Fanaei, H. (2019). Effect of swimming training on levels of asprosin, lipid profile, glucose and insulin resistance in rats with metabolic syndrome. Obesity Medicine, 15(2019) 100111. https://doi.org/10.1016/j.obmed.2019.100111.
Pawitan, J.A., Leviana, M., Sukmawati, D., Liem, I.K., Margiana, R., & Tarcisia, T. (2017). Prospect of umbilical cord mesenchymal stem cell culture waste in regenerative medicine. Journal of Global Pharma Technology, 9(7), 1-5. http://152.118.76.18:8080/jspui/handle/123456789/7040.
Ramos, J.S., Dalleck, L.C., Tjonna, A.E., Beetham, K.S., & Coombes, J.S. (2015). The impact of high-intensity interval training versus moderate-intensity continuous training on vascular function: a systematic review and meta-analysis. Sports Medicine, 45(5), 679-692. https://doi.org/10.1007/s40279-015-0321-z.
Rebello, C.J., Kirwan, J.P., & Greenway, F.L. (2020). Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link? International Journal of Obesity, 44, 1810–1817. https://doi.org/10.1038/s41366-020-0640-5.
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., & York, B. (2016). Asprosin, a fasting-induced glucogenic protein hormone. Cell, 165(3), 566-579. https://doi.org/10.1016/j.cell.2016.02.063.
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2016). Age-related changes in AMPK activation: role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways. Ageing Research Reviews, 28, 15-26. https://doi.org/10.1016/j.arr.2016.04.003.
Seo, D.Y., Ko, J.R., Bang, H.S., & Han, J. (2020). Exercise decreases hepatic asprosin in stz-induced diabetic rats. Metabolism-Clinical and Experimental, 104S(2020) 154076. https://doi.org/10.1016/j.metabol.2019.12.022.
Ugur, K., & Aydin, S. (2019). Saliva and blood asprosin hormone concentration associated with obesity. International Journal of Endocrinology. 2521096, 8. https://doi.org/10.1155/2019/2521096.
Wang, Y., Qu, H., Xiong, X., Qiu, Y., Liao, Y., Chen, Y., & Zheng, H. (2018). Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion. Mediators of Inflammation. 9471583, 7. https://doi.org/10.1155/2018/9471583.
Weston, K.S., Wisløff, U., & Coombes, J.S. (2014). High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. British Journal of Sports Medicine, 48(16), 1227-1234 https://doi.org/10.1136/bjsports-2013-092576.
Wilson, L.F., Baade, P.D., Green, A.C., Jordan, S.J., Kendall, B.J., Neale, R.E., & Whiteman, D.C. (2019). The impact of changing the prevalence of overweight/obesity and physical inactivity in Australia: an estimate of the proportion of potentially avoidable cancers 2013–2037. International Journal of cancer, 144(9), 2088-2098. https://doi.org/10.1002/ijc.31943.
Yang, Z., Jiang, J., Huang, J., Zhao, Y., Luo, X., & Song, L. (2020). Effect of high-fat diet and exercise on asprosin and CTRP6 expression in subcutaneous and retroperitoneal adipose tissues in rats during mid-gestation. Journal of Southern Medical University, 40(10), 1406-1414. https://doi.org/10.12122/j.issn.1673-4254.2020.10.05.
Yuan, M., Li, W., Zhu, Y., Yu, B., & Wu, J. (2020). Asprosin: a novel player in metabolic diseases. Frontiers in Endocrinology, 11, 64 .  https://doi.org/10.3389/fendo.2020.00064.
Zarei, M., Khodakheyr, J. N., Rashidlamir, A., & Montazeri, A. (2021). The effect of combined resistance aerobic exercise training on concentrations of asprosin and complement C1q tumor necrosis factor-related protein-1 in men with type 2 diabetes. Sport Sciences for Health,17, 863–871, 1-9. https://doi.org/10.1007/s11332-021-00738-7.
Zhang, L., Chen, C., Zhou, N., Fu, Y., & Cheng, X. (2019). Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride. Clinica Chimica Acta, 489, 183-188. https://doi.org/10.1016/j.cca.2017.10.034.
Zhang, X., Jiang, H., Ma, X., & Wu, H. (2020). Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus. Journal of Diabetes Investigation, 11(2), 349-355. https://doi.org/10.1111/jdi.13148.